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Introduction
Adhesive disease and its complications, mainly caused by 
a mechanical bowel obstruction, is one of the major health 
problems due to its diverse impact on the growing organism 
[1, 2]. The high- incidence disability due to this pathology is 
still a topic under discussion. Currently, there is no unani-
mously accepted standard for the diagnosis, treatment and 
prophylaxis strategies in children. The actuality of this issue 
is determined by its high frequency, polymorphism of clini-
cal manifestations, its severity and unpredictable evolution, 
poor prognosis, and associated complications. Recent stud-
ies have defined the long-lasting challenges related to this 
intra-abdominal complication. However, the latest success-
ful researches in pathophysiology and molecular biology 
have opened new avenues in the assessment and prophy-
laxis of adhesion processes, by assessing the genetic factors, 
impaired cell metabolism and homeostasis that encodes the 
body’s susceptibility to this complication [3, 4].
Adhesion formation is a risk factor following all the ab-
dominal surgeries, occurring in up to 100% of cases. Ad-
hesions are more commonly to occur after the surgeries 
performed on the small bowel, colon, appendix, or uterus. 
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Abstract
Background: The adhesive disease and its associated complications, caused by adhesive mechanical bowel obstructions, mainly related to genetic causes 
and disorders of cell homeostasis, is one of the major health problems due to its diverse impact on the growing organism.  
Material and methods: The clinical study was conducted on a group of 50 children aged 1 month – 18 years old with abdominal adhesion disorders, 
complicated by bowel obstruction, following a surgical intervention. Apart from the assessment of the anamnesis, clinical, and imaging manifestations, 
traditional bio-humoral homeostatic imbalance markers, endotoxemia levels, associated complications, and comorbidities, the blood inflammatory and 
excessive fibrosis biomarkers were assessed at different clinical periods of the pathological process.
Results: A non-randomized pro- and retrospective study was carried out to assess the epidemiological, clinical and paraclinical, histopathological, 
evolutionary, preventive and treatment charcteristics in order to determine the major complication triggers following a surgical intervention on the small 
intestine, colon, appendix or uterus , as well as to highlight their possible peculiarities in children.
Conclusions: This study completed the clinicians’ views on intraperitoneal adhesion pathophysiology, thus confirming the importance  of the microbial 
factor, inflammatory mediators, activation of humoral systems due to organic cellular lesions, the extension of the inflammatory response, as well as the 
genetic factors depending on the acetylation phenotype in children.
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Adhesions are less common in surgeries on the stomach, 
bladder or pancreas. To date, there are no anatomical and 
clinical criteria to reduce postoperative complications, as 
well as there are no preventive measures to avoid adhesion 
processes, especially in children. The surgical diagnosis and 
management of abdominal diseases have an indisputable 
role in enhancing the early or supportive treatment. Despite 
some progress, there are still many questions, which arise 
the constant interest of the scientific world [5].
Additionally, a better understanding of the adhesion 
processes, which result in mixed bowel obstruction and 
might potentially evolve into multiple organ failure and 
intestinal failure, could help in developing a more effective 
approach in order to reduce complications, disabilities and 
the number of deaths. In the last decades, the nosological 
classification of adhesion processes has been carried out by 
describing their main clinical, imaging, histopathological 
and evolutionary patterns [6].
The purpose of the study. Complex clinical and para-
clinical examination methods (biochemical, bacteriologi-
cal, imaging, and histopathological assessment) were used 
to develop and optimize the diagnostic schemes, prognosis, 
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treatment, and prophylaxis in pediatric adhesive disease 
and its complications.
Material and methods
The clinical study was carried out at Natalia Gheorghiu 
Scientific Center of Pediatric Surgery, in collaboration with 
the Biochemistry Laboratory of Nicolae Testemitanu State 
University of Medicine and Pharmacy on a group of 50 chil-
dren aged from 1 month to 18 years old, diagnosed with ab-
dominal adhesion complicated by bowel obstruction, who 
underwent surgical interventions during 2011-2019. The 
research project was approved by the Research Ethics Com-
mittee of Nicolae Testemitanu State University of Medicine 
and Pharmacy (favorable opinion dated of 13.05.2015, min-
utes No 55). The anamnesis, clinical and imaging data, tra-
ditional bio-humoral homeostatic imbalance markers, en-
dotoxemia levels,  associated complications and comorbidi-
ties were assessed, as well as the following biomarkers: the 
level of nitric oxide (NO) metabolites and serum concen-
tration of protein-bound hydroxyproline [7]; serum leve- 
ls of interleukin 1β (IL-1β) via ELISA method, by using the 
“Imunoteh” test kit, USA; C-reactive protein (PCR) was es-
timated via the Beckman test kit, Ireland; the serum sialic 
acid (SA) and ceruloplasmin concentration was assessed via 
the photometric assay [8]; the intensity of the acetylation 
processes necessary to establish the acetylation phenotype 
was assessed by determining the N-acetyltransferase acti-
vity [9]; the serum copper level was determined via ELITEH 
test kit, France. The comprehensive extemporal biochemi-
cal assessment was performed in all patients from the study 
group, at different clinical and evolutionary pathological 
stages of the clinical course viz. inpatient and preoperative 
care, the 4th postoperative day, at time of discharge and 
follow-up period.
The morpho-histopathological assessment was carried 
out in 46 patients, who underwent a surgical intervention 
for intraperitoneal adhesions, in order to assess the prog-
nosis, medical and surgical management, and prophylaxis 
of adhesive bowel obstruction.  This study included macro- 
and microscopic examination of various abdominal adhe-
sions, as well as in purulent peritonitis, acute appendicitis 
(catarrhal, phlegmonous, and perforated gangrenous), in-
tra-peritoneal organ involvement, etc. The biopsy samples 
were retrieved from different anatomical sites, namely from 
occluded intestinal segments, mesentery, omentum, entero-
stomic portions, vermiform appendix, and intraperitoneal 
lymph nodes. Thus, the microscopic examination revealed 
fragments of bowel, omentum, adhesive bands, and vermi-
form appendix. The fragmented pieces had from 3-4 to 10 
tissue sections. Tissue sections were stained with hematoxy-
lin -eosin and picrofuxin by Van-Geison’s method, whereas 
a 10% formalin solution was used to fix and study the sam-
ples under microscope with a 7 – eyepiece, using the 10x 
objective.
The test findings were evaluated via the Microsoft Of-
fice Excel program; the Student-test was applied to process 
the statistical mean values and Fisher criterion for coherent 
selections. To determine the statistical significance, the P 
value should have been less than 0.05 [10].
Results
The study included patients diagnosed with adhesive 
bowel obstruction. The non-randomized pro- and retro-
spective study was carried out to assess the epidemiological, 
clinical and paraclinical, histopathological, evolutionary, 
preventive and treatment peculiarities, as well as to deter-
mine the major complication triggers and their possible fea-
tures with regard to currently available medical literature. 
The study group included 50 patients. Sex distribution pat-
tern revealed a higher male to female ratio, viz. 2: 1.  Accord-
ing to the place of residence, most children were from rural 
areas – 85% compared to those from urban areas – 15% of 
patients aged 6-12 years. The patients who were enrolled 
within the study were diagnosed with bowel obstruction, 
following a postoperative adhesive bowel obstruction and 
strangulation. These patients required a surgical interven-
tion and were divided based on endotoxemia levels.  Twenty 
patients, who suffered from adhesive bowel obstruction but 
showed successful conservative treatment outcomes, were 
excluded from the study.
Symptoms at admission included abdominal pain – 
100%, intestinal motility disorders, dilated intestinal loops, 
hyperleukocytosis, intestinal transit disorders – 100%, vomi- 
ting – 100%, fever – 70%, tachycardia – 100%, tachypnea 
– 90%, etc. The time intervals from the onset and time of 
admission was 24-48-72 hours. Most children from the 
present study were hospitalized with severe and extremely 
severe abdominal adhesive pathological process, accounting 
for 42% of the total number of studied patients. Thus, 68% 
of patients were admitted with late clinical-evolutionary 
stages, later than 24-48-72 hours from the onset, which in-
fluenced the subsequent evolution, prognosis and the dis-
ease-specific survival rate.
It should be mentioned that patients with intraperito-
neal inflammatory processes, hospitalized within the first 24 
hours after the disease onset made up 58% of cases, over 36 
hours – 24%, and over 2-7 days – 10%. Two patients under-
went relaparotomy on the 5th postoperative day, followed 
by inter-intestinal band excision. 
A severe disease onset was reported in 92.6% of cases, 
manifested by abdominal pain syndrome in  82.5% of cases, 
nausea and repeated vomiting episodes – 70%, insomnia – 
58%, and anorexia – 70%. Constipation was present in 47% 
of patients aged over 3 years old and 26% of patients showed 
no changes in bowel movement frequency and transit pat-
terns. 27% of patients had loose stools, thus being hospital-
ized within the Intestinal Disease Units in 9% of cases. 4% of 
children aged up to 3 years, were primarily diagnosed by the 
family doctor as experiencing a reaction to teething. These 
children were admitted at the late stages of the disease at 
specialized Surgery Departments.
54% of patients exhibited mild abdominal pain due to 
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the underlying acute respiratory viral infection, thus being 
late referred to surgery departments. 90% of patients had 
local peritoneal signs (muscular defense, abdominal bloat-
ing, lack of intestinal transit, etc.). Abdominal asymmetry 
was present in 49% of patients with intraperitoneal pain 
syndrome, whereas 18% of cases had a specific tense abdo-
men, 90% – positive peritoneal signs, 39% – different endo-
toxemia levels (fever, hyperemia, tachypnea, impaired skin 
microcirculation; 12 children showed a confusional state re-
lated to primary central nervous system (CNS) involvement 
and clinical features of a systemic infection, hemodynamic 
changes and homeostasis; 8 children exhibited coagulopa-
thy with bleeding manifestations (systemic hemorrhage and 
thrombocytopenia).
Paraclinical examinations revealed hyperleukocytosis 
in 88.8% of patients, leucopenia – 16.4%, thrombocyto-
penia – 10.2%, an increased ESR – 86.2%, anemia – 66.6 
%, hypoproteinemia and dysproteinemia – 71.2%, hyper-
transaminasemia – 20.1%, low prothrombin index – 74.4%, 
high fibrinogen concentration – 58.6%, and hydroelectro-
lytic disorders  were found in 91.1% of patients.  Imaging 
scans included abdominal ultrasound exam, barium sulfate 
contrast of gastrointestinal (GI) transit time, computed to-
mography (CT) (in 5 patients), which allowed to diagnose a 
positive intestinal obstruction.
Acetylation phenotype was determined in all 50 patients. 
The studies revealed that of the 50 patients, who underwent 
clinical and biochemical assessment, 32 (65%) patients ex-
hibited fast acetylators, whereas 18 (35%) – slow acetylators.
Some biochemical and immuno-biochemical changes 
were particularly highlighted in children with different 
acetylation phenotypes.
The findings presented in table 1 show that the nitric ox-
ide (NO) metabolite level was significantly higher at admis-
sion time, thus exceeding 3-10 times the control values. At 
the same time, the highest NO values were recorded in ad-
hesive processes, following an apendicectomy, as well as in 
fecal peritonitis (almost 10 times higher compared to that of 
the control group). However, this index gradually decreased 
on the first day postoperatively and subsequently, showing 
its minimum values of 2.2-2.8 times higher compared to the 
control group, which is considered as a reference range for 
the 9th-10th day of hospital discharge.
Similar, though milder changes were recorded in dynam-
ic assessment for serum cytokine IL-1β, the data obtained 
(tab. 2) showed that serum IL-1β concentration was signifi-
cantly higher at admission, viz. exceeding 3-7 times the con-
trol group values. At the same time, the highest serum IL-1β 
values were recorded in adhesive processes in fecal perito-
nitis and in intraperitoneal adhesive processes (almost 7 
times higher compared to that of the control group). Howe- 
ver, this index gradually decreased on the 1st day postope-
ratively and subsequently, the minimum values exceeding 
1.6-2.1 times higher than the control group indices, which 
is considered as a reference range for the 9th-10th day of 
hospital discharge.
The serum C-reactive protein (CRP) level increased sig-
nificantly at admission time, exceeding 4-12 times the con-
trol values and maintained high values on the 1st and 3rd 
day postoperatively. However, it gradually decreased on the 
5th day postoperatively, whereas at discharge, the CRP level 
was 1.4-2.6 times higher than the reference values, though 
showing no statistical relevance (tab. 3).
Table 1
Dynamic alterations of serum nitric oxide metabolites levels (nO, µmol / l) in abdominal adhesive  
processes of different origin 
Research stages
Disease types
A.  Acute phlegmon-
ous appendicitis
B.  Adhesive pro-
cesses after appendi-
cectomy 
C.  Adhesive proces-
ses in fecal   perito-
nitis
D. Adhesive bowel 
obstruction





7.4 ± 1.12** 987% 8.1 ± 0.95*** 1080% 4.3 ± 1.02** 573% 3.1 ± 0.44*** 413%
1st day, postoperatively
2.9 ±  0.56**
P1>0.5
387%
6.3 ± 1.14**  p1>0.5
840%
7.4 ± 0.86***  p1>0.5
987%
4.5 ± 0.89**  p1>0.5
600%
3.7 ± 0.41***  p1>0.5
493%
3rd  day,  postoperatively
3.5 ± 0.81**   p1<0.05  
467%
3.8 ± 0.45*** p1<0.01
507%
8.5 ± 0.72***  p1>0.5
1138%
3.6 ± 0.45**  p1>0.5
480%




1.7± 0.09**  p1>0.5
227%
2.1± 0.38**  p1<0.01
280%
7.3 ± 0.31***  p1>0.5
973%
2.3 ± 0.51**  p1>0.5
307%
2.8 ± 0.37**  p1>0.5
373%
At discharge




1.86 ± 0.24**  
p1<0.001
248%
1.3 ± 0.42 p1<0.05
173%
1.7 ± 0.29*  p1<0.05
227%
Control group
0.75 ±  0.08 
100%
0.75 ± 0.08 
100%
0.75 ± 0.08 
100%
0.75 ± 0.08 
100%
0.75 ± 0.08 
100%
Note: Statistical significance if compared to control values - * - p <0.05; ** - p <0.01;  *** - p <0.001; if compared to the 1st stage - p1<0.05; p1<0.01; p1<0.001.
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Alterations in serum sialic acids and protein-bound hy-
droxyproline (tHP) levels in children with dynamic adhe-
sion processes, depending on acetylation phenotype and 
treatment approach are shown in Table 4. Therefore, the 
levels of sialic acids and tHP at admission and on the 1st 
day postoperatively were significantly higher than those 
from fast-acetylators control group. However, this index 
decreased on the 3rd day postoperatively, having its mini-
mum values on the 9th-10th day, at discharge. A similar dy-
namic pattern was recorded for slow acetylators, although 
the serum sialic acids and tHP levels were lower than in fast 
acetylators, whereas the highest concentration was recorded 
on the 1st day postoperatively, which decreased to normal 
values at the time of discharge (tab. 4).
The serum copper concentration in slow acetylators 
showed a statistically significant increase in the early stages, 
having the highest values on the 5th day postoperatively, fol-
lowed by a decrease on the 10th -15th day, at discharge (tab. 
5). The serum copper level in fast acetylators increased on 
the 1st postoperative day, then decreased to its lowest values 
on the 5th day postoperatively and afterwards returned to 
its control values.
The level of ceruloplasmin, a copper-containing protein 
in slow acetylators elevated after surgery, showing the hi-
Table 2
Dynamic alterations of serum cytokine IL-1β levels (μg / l) in abdominal adhesive processes of different origin 
Research stages
Disease types
A.  Acute phleg-
monous appen-
dicitis
B.  Adhesive pro-
cesses after appen-
dicectomy
C.  Adhesive processes 
in fecal   peritonitis
D. Adhesive bowel 
obstruction 
E.  Intra-peritoneal 
adhesions
At admission 44.6 ± 6.81* 231% 98.4±10.26** 510% 136.4 ±11.35*** 707% 75.1 ± 12.27*  389% 131.7 ± 10.71**   682%
1st day, postopera-
tively
57.9 ± 7.53** p1>0.5
300%






87.5 ± 10.34**  p1>0.5
453%





48.1 ± 6.81*  p1>0.5
249%
91.7 ± 9.75** p1>0.5
472%
89.4 ± 6.91**  p1<0.01
463%
75.6 ± 8.91**    p1>0.5
392%
108.1±11.87***             
p1>0.5
560%
5th  day, postopera-
tively
34.1 ± 9.17 p1>0.5
177%
40.1 ± 6.68* p1<0.01
208%
52.7 ± 5.86**  p1<0.001
273%
55.2 ± 10.13*  p1>0.5
286%
58.6 ± 14.21*   p1<0.01
294%
At discharge 26.5 ± 5.84 p1>0.5
173%
31.1 ± 3.11  p1<0.05
161%
31.7 ± 2.42  p1<0.001
164%
40.7 ± 9.77   p1<0.05
211%
32.8 ± 10.35   
p1<0.001
170%
Control group 19.3 ± 4.5
 100%
19.3 ± 4.5 
100%
19.3 ± 4.5 
100%
19.3 ± 4.5 
100%
19.3 ± 4.5 
100%
Note: Statistical significance if compared to control values - * - p <0.05; ** - p <0.01; *** - p <0.001; if compared to the 1st stage - p1<0.05; p1<0.01; p1<0.001.
Table 3
Dynamic alterations of serum C-reactive protein (CRP) level (mg / l) in abdominal adhesive  
processes of different origin
Research stages
Disease types
B.  Acute phlegmon-
ous appendicitis
C.  Adhesive pro-
cesses after appen-
dicectomy
D.  Adhesive proces-
ses in fecal   perito-
nitis
E. Adhesive bowel 
obstruction 
F.  Intra-peritoneal 
adhesions
At admission 20.2 ± 4.36**  388% 41.7±8.16***  802% 62.0±7.83** 1192% 9.8±2.43 188% 29.3±8.72**   563%
1st  day, postopera-
tively










2nd  day, postopera-
tively
































12.3±6.58      p1>0.5
237%
Control group 5.2 ± 0.1  100% 5.2±0.1  100% 5.2±0.1  100% 5.2±0.1  100% 5.2±0.1           100%
Note: Statistical significance if compared to control values - * - p <0.05; ** - p <0.01; *** - p <0.001; if compared to the 1st stage - p1<0.05; p1<0.01; p1<0.001.
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ghest values on the 5th day postoperatively, then returned 
to normal ones at discharge. In fast acetylators, the dynam-
ics of ceruloplasmin was similar to that of slow acetylators, 
howe-ver, being statistically irrelevant (tab. 5).
The bacteriological studies were carried out according 
to the developed algorithm and the study design, present-
ed in table 6, followed by the diagnosis and monitoring of 
the bacterial flora within the abdominal cavity, blood and 
wound. The results showed a predominance of Gr. Flora - 
50% and polybacterial associations – 60%.
Thus, patients with diffuse purulent-fibrinous peritonitis 
that was related to an underlying long-lasting and persistent 
intestinal paresis, developed grade I-III dysbiosis soon af-
ter surgery, being  determined at all levels of GI tract. The 
following pathogens were reported in 3 patients aged 2-5 
years with ileo-stomata: enteroccocus and Klebsiela strains. 
The prophylaxis of intestinal dysbiosis was corrected via 
selective decontamination methods that included probiot-
ics (Linex, Opefera, Acidolac, Lactobex Baby). A reduced 
pathogenic population and small amounts of lactobacteria 
Table 4
Dynamic alterations of serum sialic acid and protein-bound hydroxyproline (tHP) levels  in children with serum 
abdominal adhesive processes of different origin, depending on acetylation phenotype and treatment approach 
Indices Serum sialic acid level Serum protein-bound hydroxyproline (tHP) level
Research stages Slow acetilators Fast acetilators Slow acetilators Fast acetilators
At admission 3.2±0.18***  152% 3.5±0.21*** 167% 131.7±6.54*   122% 136.9±8.42* 126%
























At discharge 2.2±0.11  100% 2.3±0.17   114% 102.3±7.15   110% 110.3±8.12   119%
Control values 2.1±0.19     100% 2.1±0.19   100% 108.3±6.18   100% 108.3±6.18   100%
Note: Statistical significance if compared to control values - * - p <0.05; ** - p <0.01; *** - p <0.001; if compared to the 1st stage - p1<0.05; p1<0.01; p1<0.001.
Table 5
Dynamic alterations of serum copper and ceruloplasmin levels in children with serum abdominal adhesive processes 
of different origin, depending on acetylation phenotype and treatment approach 
Indices Serum copper level, µM/l Serum ceruplasmin level, mg/l
Research stages Slow acetilators Fast acetilators Slow acetilators Fast acetilators
At admission 27.1±2.1*  132% 25.4±2.4  124%
p>0.5
377.3±26.8    107% 381.3±28.9    108%
p>0.5
1st  day, postoperatively 38.6±3.4**   188% 36.1±3.8** 176%
p>0.5
446.5±25.6    126% 397.6±41.2     112%
P<0.05
3rd  day, postoperatively 32.7±4.1**    160% 33.1±2.4**    161%
p>0.5
380.7±19.8   108% 371.3±25.7   105% 
p<0.05
5th  day, postoperatively 31.2±4.1*   152% 23.8±2.1***  116% p>0.5 368.3±21.2    104% 361.5±19.7  102% 
p<0.05
At discharge 24.8±3.1   121% 22.7±2.4    111%
p>0.5
363.8±24.6   103% 359.4±21.9   101%
p>0.5
Control values 20.5±1.4   100% 20.5±1.4   100% 354.1±22.7   100% 354.1±22.7   100%





Bacterial agent Abs. P±ES,%
Gr. - E. coli 25 50±5.4%
Ps. Aeroginosa 5 10±1.2%
Kl. Pneumonae 7 14±2.9%
Proteus 4 8±1.4%
Gr. + St. aureus 13 26±1.7%
Str. Epidermidis 8 16±0.4%
Candida albicans 10 20±2.8%
Intestinal dysmicrobism, grade I-IV 30 60±5.7%
2 bacterial association 12 24±1.3%
3 bacterial association 18 36±0.8%
Anaerobes Clostridium 5 10±0.8%
Antibiotic-resistant strains 8 16±1.8%
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allowed optimizing the time of stromal closure, which was 
performed on the 2nd and 4th month after the application. 
This therapeutic approach along with antiadhesion drugs 
(Serrata, Longidaza 3000ME, rectal suppositories, Cuprinil 
per oral, Fermencol – electrophoresis and local gel, as well 
as the use of anti-inflammatory and immunomodulatory 
medication – Wobenzym) allowed optimizing the stromal 
closure time that was performed on the 2nd and 4th month 
after their application by latero-lateral (2) and termino-ter-
minal (1) anastomoses, followed by positive treatment out-
comes at early and late stages. The children were aged from 
2.3-5 years old.
Microscopic histopathological assessment of the biopsied 
material revealed presence of celluloid fat, crossed by inter-
mediate layers of connective tissue, divided into irregular-
sized cellulo-adipose lobules, often round or oval-shaped. 
The connective spaces between the cellulo-adipose lobules 
varied in thickness, being made up of connective fibers that 
were parallel to a significant number of fibrocytes (fig. 1 
and 2).
There was found a number of areas with swollen and ho-
mogenized connective fibers, located within a homogenized 
ground substance with the high number of fibrocytes. The 
blood vessels were unevenly dilated and hyperemic. The cel-
lulo-adipose tissue that was adjacent to the infiltration areas 
exhibited an increased concentration of fibroblasts (massive 
leukocyte infiltraion), which proliferated from the connec-
tive spaces. The analysis of the obtained findings regarding 
the small bowel portion, severe inflammatory changes of 
the peritoneum and intraperitoneal organs, as well the high 
level of body sensitivity to determine the inflammation de-
gree was carried out. Subsequently, a more in-depth study 
was performed on the biopsy samples of the intraperitoneal 
adhesions, retrieved from the same anatomical and patho-
logical sites, as well as on the neuronal damage of the Auer-
bach plexus.
Most of hospitalized children with abdominal adhesions 
were admitted with severe or extremely severe health condi-
tion that made up 71.5% of all patients included within the 
study group. According to the research data, 78.9% of pa-
tients were hospitalized in late clinical evolutionary stages, 
which had an extremely negative impact on further evolu-
tion and the prognosis of the disease.
It should be noted that a significant number of children 
(70%) were reported with concomitant cardiovascular, re-
spiratory, renal-urinary, and musculoskeletal disorders, 
diabetes mellitus, acute mesadenitis, phlegmonous diver-
ticulitis, Flexner dysentery, hemorrhagic vasculitis, parasit-
ic diseases (enterobiosis, ascariosis, and hydatidosis), post-
traumatic sequelae, etc.
Antiadherent treatment. The complex antiadherent 
treatment was started intraoperatively with  a mild adhe-
siolysis, peritoneal cavity lavage, 200 ml of 5% aminoapron-
ic acid solution intraperitoneally + 2 ampoules of thrombin 
and abdominal cavity drainage with glove lamellae in the 
right iliac fossa.
The antiadherent treatment approach included collagen 
synthesis inhibitors – Cuprinyl-penicillamine and bacterial 
collagenase – Clostridiopeptidase A for removing collagen 
fiber formation. Penicillamine was administered from the 
2nd-3rd day postoperatively, doses were based on the child’s 
age: 0.15 / 1 capsule – in children up to 5 years, 0.3 / 2 cap-
sules – in children aged from 5 to 12 years old and 0.4 / 3 
capsules – over 12 years, once / per day. The treatment lasted 
from 10-14 days. No side effects were reported regarding the 
use of penicillamine.
Clostridiopeptidase A was used as ultrasonophoresis 
with iruxol, a combination of clostridiopeptidase A and 
chloramphenicol. Ultrasonophoresis with iruksol was ap-
plied on the anterior abdominal wall on the 2nd-3rd day 
after surgery. The ultrasound UTP-1 device used a pulsating 
mode, at one pulse /second frequency and 0.4 W / cm inten-
sity. The course of treatment included up to 10 procedures.
Children with adhesive intestinal obstructions, who un-
derwent laparotomy, were given postoperative treatment on 
the 1st-2nd day by using electrophoresis or collalizine injec-
tions nearby the plague, followed by galvanization,  instead 
of ultrasonophoresis+iruksol.
The antiadherent treatment scheme also included Fer-
Fig. 1. Productive perivisceritis evolving into sclerosis, collagen 
fiber bundles with solitary fibrocytes. Van gieson staining.  
10-x eyepiece, 20-x objective.
Fig. 2. Infiltrative-productive cellulitis, fibrocellular tissue 
with solitary or group lipocyte inclusions. Hematoxylin-eosin 
staining. 10-x eyepiece, 20-x objective.
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mencol, containing a series of highly active collagenases that 
enabled the hydrolysis of both collagen peptide bonds and 
polysaccharides that form the connective tissue. 15 proce-
dures of electrophoresis with Fermencol gel were applied on 
the postoperative wound. Longidase 3000ME with immu-
nomodulating and collagenolytic effects was also applied.
Treatment of adhesive syndrome. The complex treat-
ment approach of the adhesive syndrome was developed at 
Natalia Gheorghiu Scientific Center of Pediatric Surgery, 
IMPH IMC that included the following major principles: 
•	 Food intake suppression;
•	 Rebalance of the hydroelectrolytic, acid-base, and 
metabolic disorders under constant and individual 
monitoring;






According to the assessed changes, the minimal resusci-
tation treatment was based on the following complex inves-
tigations: clinical, imaging, biochemical, and bacteriological 
tests, leukocyte intoxication index, etc., thus justifying the 
following therapeutic algorithm in the preoperative stage 
(to reduce the endogenous intoxication and improve critical 
organ functioning, particularly of the GI tract): 
•	 Rebalancing of hydroelectrolytic and metabolic disor-
ders;
•	 Anemia correction;
•	 Antibiotic therapy in providing resolution of the in-
fectious process (cerulopasmine, aminoglycosides, 
metronidazole, etc.);
•	 Use of hepatoprotective agents;
•	 Gastric and bowel decompression;
•	 Fever treatment;
•	 Symptomatic medication (vasoactive, corticosteroid, 
and cardiotonic drugs).
The most appropriate rebalancing approach was surgery, 
followed by patient detoxification and fast recovery. The 
surgical method of choice and its duration depends on the 
diagnosed condition, the evolutionary stage, complications, 
the patient’s biological field, etc.
Tactical and technical aspects of surgical interventions / 
repeated interventions were aimed: 
•	 To undergo repeated laparotomy or relaparotomy with 
peritoneal cavity drainage using glove lamellae;
•	 Adhesiolysis;
•	 To remove obstruction of the GI tract and provide 
proper bowel movement;
•	 To restore the digestive tract integrity by applying in-
testinal anastamosis (term-terminal, termino-lateral, 
and latero-lateral);
•	 To eliminate the source of peritoneal contamination 
and restore the abdominal cavity.
 To achieve these purposes, a primary surgery or a re-
peated laparatomy is required, the latter could be performed 
via the surgical or median approach. Previous laparotomy 
was considered as the optimal access pathway.
The postoperative treatment is based on the following 
objectives:
•	 Nasogastric intubation (reduces abdominal disten-
sion, avoids repeated vomiting and prevents from en-
tering into the upper respiratory tract, improves pul-
monary ventilation);
•	 Oxygen therapy in patients with clinical signs of res-
piratory failure;
•	 Clinical and biological follow-up and specific treat-
ment adjustments;
•	 The preoperative antibiotic therapy is continued based 
on clinical criteria, then modified depending on the 
antibiotic-susceptibility testing results;
•	 Stimulation of intestinal peristalsis (Prozerini, Ceru-
cal, and Quamatel IV solution);
•	 Selective decontamination (Linex, Opefera, Acidolac, 
Probiotic, Lactobex Baby, Ferzim plus, AERIS, etc.);
•	 Hydroelectrolytic and metabolic rebalancing;
•	 Early patient mobilization;
•	 Hygiene and dietary regimen aimed to  resume the pa-
tient's natural diet;
•	 Patients’ local evolution (peritoneal, abdominal) and 
overall condition follow-up;
•	 Hemodynamic monitoring (pulse rate, respiration, 
temperature, blood pressure, central venous pressure, 
diuresis, etc.);
•	 Immunocorrection therapy by using amino acids, 
which increase protein synthesis and  decrease pro-
teolysis, as well as administration of essential polyene 
fatty acids Omega3, Fish Oil Jr;
•	 Antiadherent  treatment according to the developed 
schemes and symptomatic medication;
•	 Plasmopheresis, if required.
The most difficult stage of the above mentioned treat-
ment approach is the antibacterial one, due to its long-last-
ing antibiotic administration (before surgery), followed by 
the formation of antibiotic-resistant strains, high virulence 
of microbial agents against the underlying low-level resis-
tance of the growing body, detection of microbial associa-
tions, and higher incidence of allergic reactions. Preopera-
tive patient preparation for improving and restoring vital 
functions should not last less than 2 hours and not exceed 
6 hours.
Discussion 
The study was based on a complex multi-planar analysis 
of clinical observation data, comprehensive laboratory and 
imaging methods, morphology, mathematical assessment of 
marker indices in basic pathologies, as well as on medical 
and surgical treatment outcomes in 50 children aged from 
1 month -18 years old, who underwent abdominal surgery.
It should be mentioned that all children were diagnosed 
via minimally invasive methods, namely, X-ray, imaging, 
and laboratory investigations, taking into account their 
medical history, type of surgical intervention, primary dis-
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ease, and previous abdominal surgeries, in order to find the 
best treatment solution in terms of the type, clinical picture, 
clinical and evolutionary stage, and  acute phase patterns 
of the disease. Since suspected complications are the first 
information-gathering step of the diagnostic process, all 
patients with abdominal surgical infections require a care-
ful medical interviewing. Moreover, most apparently irrel-
evant details related to less specific clinical manifestations 
and minimal changes found in usual investigations might 
be essential for establishing an early effective diagnosis and 
prevention, as well as justify an adequate treatment, based 
on currently available and accepted disease diagnosis, pre-
vention and management [11, 12].
As regarding the pathology-related problems, they arose 
from numerous factors involved in the etiopathogenesis 
of these pathological conditions, which might cause major 
changes in different homeostatic systems of the growing 
body [13].
It should be noted that further studies are required to 
assess the risk factors, in order to develop specific preven-
tive measures and a differentiated individualized treatment 
[14, 15].
The comprehensive study of the anamnestic data regard-
ing the basic condition and its associated complications 
allowed concluding that the clinical features were charac-
terized by an acute onset and various clinical symptoms. It 
should also be mentioned that the severe patient’s condition 
developed considerably on a previously underlying disor-
der, which made it difficult to properly assess the child’s 
condition. Furthermore, most patients had previously un-
dergone surgical treatment in the late stages of destructive 
acute appendicitis and appendicular peritonitis, which, 
apart from challenges in establishing the primary diagnosis 
and medical-surgical approach, contributed significantly to 
being associated with complications or conditions that re-
quired relaparatomy.
 The development of complications is mainly due to the 
late diagnosis of acute appendicitis, errors in the medical 
and surgical treatment of intestinal obstruction, inadequate 
clinical and evolutionary assessment of peritonitis, inade-
quate abdominal cavity drainage, and inappropriate use of 
enterostomal therapy, which resulted in adhesion develop-
ment, long-lasting tertiary peritonitis, etc., a fact being re-
ported by a number of authors [16].
Patients enrolled within the study had a precarious bio-
logical field due to various causes and associations, as well as 
a clinical picture, characterized by an acute onset, severe signs 
of endotoxicosis (grade II-III), endotoxic shock, peritoneal 
sepsis, fever, chills, etc. Moreover, the severe child’s condition 
largely developed on an underlying pathology, thus making 
it difficult to assess the clinical and evolutionary stages of the 
disease. Most patients exhibited severe fecal peritonitis, per-
forated gangrenous appendicitis, and intestinal obstruction 
(both mechanical bowel obstructions and intestinal invagina-
tion). These children had signs characteristic of endogenous 
intoxication, septic and toxic shock, and severe microcircula-
tory disorders, followed by multiple organ failure.
The obtained findings indicated that the main sources 
of endogenous intoxication in generalized intra-abdominal 
infections are both the large peritoneal surface and the GI 
tract pathology, in case of intestinal failure. The endogenous 
infection of the patient with generalized peritonitis showed 
a “primary endogenous” character, thus contributing to se-
lective decontamination of the digestive tract in patients 
with peritonitis and abdominal sepsis. Therefore, the bac-
teriological assessment is crucially important for all stages 
of acute peritonitis management in children, namely in the 
diagnosis, postoperative antibacterial treatment and early 
diagnosis of postoperative complications based on the de-
veloped algorithm.
Recent studies have provided increasingly more evi-
dence on the importance of intestinal microbiota in the 
pathogenesis of peritonitis and in the onset of the adhesive 
diseases. This topic was given special attention since intes-
tinal microbes might play a key role in the development of 
infants and their immune system due to the immunological, 
metabolic and neurological benefits offered to the growing 
body. The specialized literature has reported that intestinal 
microflora and intestinal microbes are essential for the nor-
mal development of the child, since these help in food diges-
tion, vitamin K and B12 production , metabolism of xenobi-
otics, anti-pathogen protection, stimulation or modulation 
of the immune system , as well as provide control over the 
hypothalamic pituitary adrenal axis [17].
The imbalance of the normal gut microbiota, also called 
dysbiosis, can lead to gastrointestinal disorders, such as in-
flammatory bowel disease (IBD), irritable bowel syndrome 
(IBS), and different systemic manifestations, such as blood 
clotting and nerve conduction disorders due to vitamin 
K and B12 deficiency. There are evidences suggesting that 
several intrinsic and extrinsic factors, such as genetic varia-
tion, diet, stress, and medications, particularly antibiotics, 
can dramatically interfere with gut microbiota, resulting in 
abdominal dysbiosis [18, 19 ]. It has been proven that the 
imbalance of the normal gut microbiota, dysbiosis, and the 
immune response of the associated mucosa play a key role 
in the development of inflammatory bowel disease (IBD), 
peritoneal inflammation, endogenous intoxication, and ab-
dominal and systemic sepsis, being obviously involved in 
the intimate pathogenic, pathochemical and immunobio-
chemical mechanisms of excessive fibrous tissue formation, 
thus in developing adhesive diseases among children [20].
Complicated evolution of acute peritonitis is often caused 
by both multifactorial association of the bacterial agents and 
the antibiotic-resistant strains that increase the incidence of 
postoperative complications, which require new conceptual 
approaches and decision-making attitudes [21, 22].
There are current studies that prove the benefits of thera-
peutic strategies for managing intestinal dysbiosis via ad-
ministration of antibiotics, prebiotics, probiotics and fecal 
microbiota transplantation for IBD [23].
The concomitant disorders found in children, increased 
the risks associated with anesthesia, surgery, and postop-
erative accidents and complications, thus resulting in costly 
treatment and poor prognosis. Therefore, there is a strin-
gent need to identify the main approaches in prevention of 
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adhesive diseases in order to minimize the financial impact 
on healthcare systems [24]. 
Currently, it is highly important to improve the study as-
pects related to disease pathogenesis, predicting factors for 
developing abdominal adhesion formation and differenti-
ated treatment approaches [25]. Therefore, it is worth men-
tioning that changes found in complete blood count and 
routine plasma biochemical markers (total protein level and 
fractions, liver function tests, blood coagulation tests, iono-
gram data) of the patients included within the study helped 
to assess the severity degree of total fecal and purulent peri-
tonitis, intestinal obstructions, spontaneous intestinal fistu-
las, perforated gangrenous appendicitis in advanced clinical 
and evolutionary stages. The bacteriological investigations 
allowed monitoring the main causative pathogens of intes-
tinal adhesive disease.
Following the analysis of pre- and retrospective study 
data, based on patient’s medical observation records, sur-
gical protocols and investigation data, including specially 
developed study aassessment of molecular mediators of in-
testinal fibrosis (inflammation markers – NO, IL-1β, CRP, 
sialic acid, protein-bound hydroxyproline, ceruloplasmin, 
and serum Copper levels ) in children with different acety-
lation phenotypes.  The peculiarities of these changes were 
also established.
An increased serum nitric oxide (NO) level relates to 
the presence of an acute inflammatory process that might 
produce the abdominal adhesion formation. NO plays a 
crucial role in synthesizing from L-arginine by nitric oxide 
syntheses (NOSs). NO involves immune responses via cy-
tokine-activated macrophages, which yield high NO levels. 
Selective NO biosynthesis inhibitors and synthetic arginine 
analogues have been reported to treat NO-induced inflam-
mation [26].
The present study showed a sudden increase in  serum 
IL-1β values  at admission, with the highest levels being 
recorded in fecal peritonitis and intra-peritoneal adhesive 
processes, which  later on gradually decreased  due to the 
treatment applied, thus having minimum values  at time of 
patient’s discharge. Elevated serum IL-1β values suggest the 
presence of an acute inflammatory process, which is respon-
sible for abdominal adhesion formation. IL-1β, also known 
as leukocyte pyrogen, endogenous leukocyte mediator, 
mononuclear cell factor, and lymphocyte activation factor, 
is an important mediator of variety of cell activities, includ-
ing cell proliferation, differentiation, and apoptosis. [27]. 
Induction of cyclooxygenase-2 (PTGS2/COX-2) by this 
cytokine in the central nervous system (CNS) is found to 
produce inflammatory pain hypersensitivity. [28]. The ex-
cessive IL-1 production is harmful and contributes to devel-
oping inflammatory diseases, autoimmune encephalomyeli-
tis, rheumatoid arthritis, gout and other disorders. [29]. It 
has also been suggested that the release of IL-1β, mediated 
by inflammasomes, might be a strictly cytolysis-induced 
event due to necrosis or pyroptosis. Pyroptosis or caspase 
1-dependent cell death is initiated by a cascading activation 
of inflammasomes, which leads to the release of IL-1β [30].
The C-reactive protein (CRP) marker of acute inflam-
matory response was also assessed within the research, 
showing significantly higher values in the clinical and evo-
lutionary stages of the pathological process. Moreover, the 
high values found  in the early research stages, although 
slowly decreasing due to the treatment applied, were still 
elevated at time of discharge in both post-apendicectomy 
adhesive processes and fecal peritonitis, thus indicating the 
persistence of an inflammatory process. CRP is produced as 
a homopentameric protein, termed native CRP (nCRP) pre-
dominantly in liver hepatocytes, but can also be synthesized 
by smooth muscle cells, macrophages, endothelial cells, 
lymphocytes and adipocytes.  nCRP can dissociate at sites 
of inflammation and infection into five separate monomers, 
termed monomeric CRP (mCRP). CRP plays an important 
role in inflammatory processes and hosts responses to infec-
tion, including complement pathway, apoptosis, phagocyto-
sis, nitrogen oxide (NO) release, and cytokine production, 
primarily of interleukin-6 and TNF-α [31]. Therefore, the 
level of serum CRP reflects the intensity of abdominal in-
flammatory processes in children with adhesion processes.
Sialic acids are involved in different biological events, 
such as cell adhesion, immunity and inflammation, while 
the increasing cellular inflammatory responses due to sialic 
acids removal from ligands or cell surface receptors, show 
the clear functions of sialic acids in negative regulation of 
cellular inflammation [32]. Thus, the high level of serum 
sialic acids recorded in dynamics among children with ad-
hesion processes is related to desialized cell surfaces, thus 
proving that the inflammatory processes were more intense 
in fast acetylators compared to slow ones.
The level of protein-bound hydroxyproline (tHP) in our 
study was a truly intensifying collagen synthesis marker. 
Thus, fibrous tissue at hospitalization and on the first post-
operative day was significantly higher in fast acetylator 
group compared to slow acetylators.  However, this index 
decreased in both groups on the 3rd postoperative day on-
wards, showing its minimum values at discharge. Such a dy-
namics in tHP values can be explained by administration 
of early collagenolytic preventive treatment in rapid acetyl-
ators, a fact confirmed by recent studies [11].
The obtained results indicated an increase in cerulo-
plasmin and serum Cu level content in slow acetylators 
postoperatively, showing maximum values on the 5th post-
operative day, then returning to normal range at time of dis-
charge. The dynamics of fast acetylators indices was similar 
to that of slow acetylators, though they were no statistically 
relevant. As it is known, ceruloplasmin is an alpha 2 globu-
lin that binds copper and is synthesized in hepatocytes. 
Ceruloplasmin is important for its biological functions in 
removing excessive catecholamines and serotonin via oxi-
dation, as well as in inhibiting both serum histaminase and 
the oxidation of lipids in the cell membrane due to its anti-
inflammatory and antioxidant action. Moreover, it has been 
found that macrophage-derived ceruloplasmin contributes 
significantly to protection against inflammation and tissue 
injury in acute and chronic experimental colitis [33]. The 
functional significance of ceruloplasmin, as well as a num-
ber of copper-containing enzymes, such as cytochromoxi-
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dase, monoamine oxidase, tyrosinase, and superoxidis-
mutase, were found to exert a strong antioxidant effect of 
annihilation on superoxide radicals, thus converting  them 
into oxygen and water.
It can be concluded that the complex of specially select-
ed biochemical examinations indirectly reflect the charac-
teristics of collagen biosynthesis in children with different 
acetylation phenotypes, thus highlighting the role of acety-
lation in the development of intraperitoneal adhesion pro-
cesses in children. The specifically rapid type of acetylation 
is characteristic for children with postoperative adhesive 
diseases. Adhesive intestinal obstruction more commonly 
occurred in fast acetylators compared to the group with 
slow acetylators. It has been proven that collagen synthe-
sis was faster in fast acetylators associated with peritoneal 
inflammation, destructive appendicitis and due to surgical 
traumas, followed by a marked endotoxemia. Therefore, a 
major genetically determined adhesion process developed. 
It should be mentioned that adhesive intestinal obstructions 
in slow acetylators exhibited milder symptoms and lower 
levels of endotoxicosis, dehydration, and acid-base balance 
changes [34].
This study results are similar to data obtained by Gol-
ubeva M.N., who reported that children with fast acetyla-
tion phenotypes (greater than 76%) exhibited a higher rate 
of adhesion formation than lysis of adhesions in peritoni-
tis [35]. The peritoneal injury in these patients leads to a 
marked intra-abdominal adhesion formation. However, 
slow acetylation phenotypes (less than 76%) showed a slow-
er acetylation process. These children had poorly marked 
or absent intra-abdominal adhesion processes , following a 
severe or repeated peritoneal trauma. The study of Yakovl-
eva O.A. et al. proved the importance of genotype and phe-
notype assessment of N-acetyltransferase as a predictor of 
bronchopulmonary diseases [36].
Acetylation is known to be crucial for metabolism. Acet-
ylation is the ability of the body (genetically determined) 
to metabolize compounds that contain amino groups. Cur-
rently, there are more than 200 genes responsible for the 
metabolism of xenobiotics, defined as foreign substances 
that enter the body through different pathways, the N-acet-
yltransferase gene being one of them, which encodes the 
N-acetyltransferase. The enzyme activity might occur in the 
liver and different tissues, which further divides people into 
two groups, namely fast and slow acetylation phenotypes. 
The recent pharmacogenetic studies have established the 
heterogeneity of the human population in terms of the abil-
ity to metabolize drugs and other xenobiotics, which largely 
determines the efficacy and safety of the therapy performed.
The antiadhesion treatment was continued in outpatient 
care conditions due to some assessed biochemical param-
eter deviations, which persisted even at 20-25 days postop-
eratively.
The biopsy samples retrieved from different segments 
of the intraperitoneal cavity during surgery have provided 
important data for all stages of the evolutionary adhesion 
processes.  The local and general reactive manifestations 
of the adhesive processes pose a significant threat on the 
growing body like in peritoneal hyperemia that is accom-
panied by the release of large amounts of biologically active 
substances into the blood flow. Furthermore, this leads to 
vascular stasis and a subsequent triggering of all mediating 
local inflammatory responses, which generally impair the 
overall condition, vital organs and proper system function-
ing. In turn, these different-origin aggressions are accompa-
nied by functional impairment of the affected region. In this 
regard, further researches should be carried out to highlight 
the molecular mechanisms of intestinal fibrosis that would 
determine the main factors contributing to fibrotic process 
in general and particularly in intestinal fibrosis [37-39].
All the anatomical and pathological adhesion types were 
made up of a fibro-conjunctival axis with dilated capillaries. 
The adhesion processes lead to a pathological development 
of a major type of acute intestinal obstruction, mainly sited 
within the small bowel. Most of adhesions caused obstruc-
tions and repeated obstructions, which turned into an acute 
intestinal occlusion.
It can be concluded that the study group included com-
plicated cases, from a clinical point of view, especially in 
patients, who required not only a complex and special di-
agnosis, but also a proper assessment of the biological field.
The assessment of homeostatic changes enabled con-
firming the crucial role of homeostasis rebalancing, by erad-
icating the pathological focus and resorption of necrotic tis-
sues, as well as removing the excessive tissue proteolysis and 
exogenous substances, thus providing optimal regeneration 
conditions.
Therefore, the complex analysis of some pathophysi-
ological mechanisms at different clinical and evolutionary 
stages in pediatric acute abdominal surgical pathology led 
to the development of a differentiated therapy, surgical ap-
proach + intensive pre-, intra- and postoperative therapy 
resulting in the most effective methods of treatment.
The obtained study results proved that the strictly indi-
vidualized management of pre-, intra- and postoperative 
medical and surgical treatment allowed improving the pre-
vious poor prognosis, by reducing serious complications, 
as well as decreasing morbidity and mortality rate in acute 
intraperitoneal inflammatory surgical pathology.
The surgical treatment requires case-by-case individual-
ized approach, taking into account the clinical, X-ray, ul-
trasound, and laboratory data, as well as the biohumoral 
features in terms of their severity and form. The beneficial 
effects of this treatment strategy are confirmed by a series of 
clinical studies [40-43].
It might be concluded that postoperative adhesions oc-
cur, following almost any abdominal surgery, whereas 20% 
of patients may have repeated episodes of adhesive obstruc-
tions, 80% of cases might experience possible relapses after 
appropriate conservative treatment, and 5% might report 
adhesive bowel obstructions, which do not improve symp-
toms even in using enemas or prokinetics , thus  a relapara-
tomy is required. Prevention of adhesion formation requires 
early diagnosis, appropriate surgical treatment, and careful 
hemostasis in anastomosis, performed by using monofila-
ment threads.
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Further in-depth studies on the peculiarities of pediat-
ric adhesion diseases are necessary in order to develop new 
strategies for prevention, diagnosis and effective, possibly 
differentiated and customized treatment.
Conclusions
1. The obtained study results were based on a group of 
50 patients aged 1 month-18 years during 2011-2018 years, 
which showed that hospital morbidity rate, due to adhesive 
bowel obstruction, tends to steadily increase, whereas the 
clinical features, complications and challenges in diagnosis 
is still a medical and surgical topic of interest. This present 
study has completed the current data on the etiopathogen-
esis of intraperitoneal adhesion processes, thus confirming 
the crucial role of the microbial factor, inflammatory re-
sponse mediators, cell and humoral immune activation, ex-
tension of the inflammatory process and the genetic factors 
due to the acetylation phenotype in children.
2. The dynamic methods of the research based on a se-
ries of modern, clinical, histological, biochemical, and bac-
teriological techniques allowed assessing the clinical and 
evolutionary disease stages, as well as the severity degree 
of its associated complications. The high level of postopera-
tive inflammatory mediators indicated an exacerbation of 
the inflammatory process and tissue hypoxia, thus being a 
risk factor in the development of intraperitoneal adhesion 
processes and resulting in poor prognosis due to a recurrent 
acute intestinal obstruction. The comprehensive diagnostic 
methods used via modern paraclinical techniques allowed 
predicting their role in the development, evolution and 
prognosis of intraperitoneal adhesion process.
3. A conservative and differentiated treatment of ab-
dominal intestinal obstruction in acute adhesion disease 
was used at first. The surgical treatment approach depended 
on the intraoperative condition, which allowed identifying 
the surgical techniques. However, all cases were likely to 
have a relapse of  intestinal obstruction, especially in chil-
dren with fast acetylation phenotype, therefore,  a 2-4 year 
follow-up is required for patients who underwent surgery, 
via regular clinical, imaging, and laboratory investigations 
and antiadherent treatment (Serrata, Fermencol, Longidase, 
Collalysin + Wobenzym – anti-inflammatory, immuno-
modulatory drugs). 
4. The scientific problem solved within this research re-
fers to complementary data on clinical, paraclinical, and im-
aging peculiarities, as well as on the biochemical markers, 
particularly of N-acetyltransferase, which provided com-
prehensive information on the acetylation type, thus justify-
ing the use of medical techniques.
5. In conclusion, further in-depth studies of this issue 
are required, particularly on the pathophysiology of colla-
gen synthesis, the prophylaxis of the adhesion process and 
targeted antiadherent treatment. The use of Longidase, Fer-
menchol, Cuprinil and anti-inflammatory drugs over the 
last years has proved to reduce the inflammatory response, 
adhesion formation in patients operated on the abdominal 
cavity. Although 100% of patients who underwent surgery 
develop adhesion processes, the antiadherent treatment 
might substantially reduce the number of cases associated 
with acute intestinal obstruction, followed by surgical treat-
ment. Therefore, a rational conservative treatment will re-
duce both the morbidity and mortality rates in acute adhe-
sive intestinal obstructions.
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